Federated Hermes, Inc. Wave Life Sciences Ltd. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.54 - $6.84 $1,132 - $2,188	320 Added 184.97%	493 $3,000
Q4 2023 Jan 31, 2024	SELL	$4.16 - $6.87 $586 - $968	-141 Reduced 44.9%	173 $0
Q3 2023 Nov 13, 2023	BUY	$3.56 - $5.75 $1,117 - $1,805	314 New	314 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.23 - $3.25 $1,354 - $3,578	-1,101 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.0 - $3.28 $2,202 - $3,611	1,101 New	1,101 $2,000

165

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $978M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.